Skip to main content

Together we are beating cancer

Donate now

Our milestones

Game-changing research
Showing 12 out of 30 results
This entry is part 30 of 30 in the series Our milestones
This entry is part 29 of 30 in the series Our milestones
Breast cancer screening

The results of a breast cancer trial we helped fund allowed surgeons to move away from ‘radical’ mastectomies towards kinder, less invasive surgeries. The results of a breast cancer trial we helped fund allowed surgeons to move away from ‘radical’ mastectomies towards kinder, less invasive surgeries.

by Fiona Conway-Jones | Analysis | 2 October 2017

2 October 2017

This entry is part 28 of 30 in the series Our milestones
This entry is part 27 of 30 in the series Our milestones
This entry is part 26 of 30 in the series Our milestones

We look at one of Cancer Research UK’s key trials, proving the drug anastrozole should be the gold standard for treating breast cancer in postmenopausal women. We look at one of Cancer Research UK’s key trials, proving the drug anastrozole should be the gold standard for treating breast cancer in postmenopausal women.

by Aine McCarthy | Analysis | 30 October 2015

30 October 2015

This entry is part 25 of 30 in the series Our milestones
Alan
  • Science & Technology
  • Health & Medicine

Our milestones: the birth of abiraterone for prostate cancer

We look back to the 1990s, and to our 'first-in-man' trial of prostate cancer drug abiraterone - a vital step in the drug's development We look back to the 1990s, and to our 'first-in-man' trial of prostate cancer drug abiraterone - a vital step in the drug's development

by Henry Scowcroft | Analysis | 21 September 2015

21 September 2015

This entry is part 24 of 30 in the series Our milestones

In the latest in Our Milestones series, we look at how Cancer Research UK scientists helped develop one of the world’s most successful cancer drugs. In the latest in Our Milestones series, we look at how Cancer Research UK scientists helped develop one of the world’s most successful cancer drugs.

by Lucy Holmes | Analysis | 26 August 2015

26 August 2015

This entry is part 23 of 30 in the series Our milestones
Telephone exchange

We go back to the 1980s, and the crucial discovery of a fundamental cancer gene by our researchers at The Institute of Cancer Research We go back to the 1980s, and the crucial discovery of a fundamental cancer gene by our researchers at The Institute of Cancer Research

by Buddhini Samarasinghe | Analysis | 29 April 2015

29 April 2015

This entry is part 22 of 30 in the series Our milestones

In the latest Our Milestones series post, we look at the role we played in the advent of a 1970s cancer treatment revolution: combination chemotherapy. In the latest Our Milestones series post, we look at the role we played in the advent of a 1970s cancer treatment revolution: combination chemotherapy.

by Aine McCarthy | Analysis | 24 March 2015

24 March 2015

This entry is part 21 of 30 in the series Our milestones
  • Science & Technology
  • Health & Medicine

The shape of all things – the year of crystallography

To mark the year of crystallography, we focus on an important scientific duo who used this powerful tool to help develop cancer drugs. To mark the year of crystallography, we focus on an important scientific duo who used this powerful tool to help develop cancer drugs.

by Kathy Weston | Analysis | 23 December 2014

23 December 2014

This entry is part 20 of 30 in the series Our milestones
Paul Nurse and Tim Hunt

In 2001, our researchers Tim Hunt and Paul Nurse won a share of the Nobel prize for physiology or medicine. We look back at their achievements. In 2001, our researchers Tim Hunt and Paul Nurse won a share of the Nobel prize for physiology or medicine. We look back at their achievements.

by Kat Arney | Analysis | 6 October 2014

6 October 2014

This entry is part 19 of 30 in the series Our milestones